Instrument Inactif

Autres langues Applied DNA Sciences Inc OTC Bulletin Board

Actions

US03815U1025

Gestion des placements et exploitants de fonds

Cours en clôture OTC Bulletin Board
- ^USD	-

13/08	BNB Plus Corp. publie ses résultats pour le troisième trimestre et les neuf mois clos le 30 juin 2026	CI
29/07	BNB Plus Corp. annonce des changements au sein de son conseil d'administration et de sa direction	CI

Autres langues

17/08	China’s Counter-Sanctions Measures: An Up-to-Date Overview
14/08	BNB Plus: Fiscal Q3 Earnings Snapshot
13/08	BNB Plus Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026
30/07	BNB Plus Corp. (BNBX) Announces Transition to Fully Internalized Digital Asset Treasury Management
29/07	BNB Plus Corp. Announces Board and Management Changes
16/07	BNB Plus Corp.(OTCPK:BNBX) dropped from S&P TMI Index
13/07	BNB Plus Receives Nasdaq Delisting Notice, Plans OTC Listing
13/07	BNB Plus Corp. (BNBX) Announces Nasdaq Delisting Determination and Transition to OTCQB Market; Company to Seek Review by Nasdaq Listing and Hearing Review Council
13/07	BNB Plus Corp.(OTCPK:BNBX) dropped from NASDAQ Composite Index
26/05	BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing
26/05	BNB Plus Corp. announced that it expects to receive $5 million in funding from Silvermine Capital Advisors, LLC, Off The Chain Capital, LLC
15/05	BNB Plus: Fiscal Q2 Earnings Snapshot
15/05	BNB Plus Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026
23/04	BNB Plus Corp. Completes Historic $1.2 Million LineaDNA™ Order
21/04	BNB Plus Corp Announces Review of Strategic Alternatives to Maximize Shareholder Value
20/04	BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value
25/03	Comstock MultiChain Fund, L P Engages with BNB Plus Corp
18/03	BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform
24/02	BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers
12/02	BNB Plus: Fiscal Q1 Earnings Snapshot
12/02	BNB Plus Corp. Reports Earnings Results for the First Quarter Ended December 31, 2025
05/02	BNB Plus Corp. Appoints James Haft as Independent Director and Nominating Committee Member, Effective February 2, 2026
05/02	BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director
27/01	BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th
27/01	BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th